PlusTherapeuticsInc . (NASDAQ:PSTV) shares saw an uptick in trading volume on Wednesday . 1,487,611 shares traded hands during trading, an increase of 982% from the previous session’s volume of 137,449 shares.The stock last traded at $7.30 and had previously closed at $7.00.
The company has a quick ratio of 0.37, a current ratio of 0.38 and a debt-to-equity ratio of 0.39.
PlusTherapeuticsInc . (NASDAQ:PSTV) last posted its quarterly earnings data on Thursday, August 15th. The company reported ($5.12) earnings per share for the quarter, topping analysts’ consensus estimates of ($9.75) by $4.63. PlusTherapeuticsInc . had a negative return on equity of 546.87% and a negative net margin of 492.45%. The company had revenue of $0.30 million during the quarter.
Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, engages in developing treatments for cancer and other diseases in the United States. The company's lead product candidate in pipeline is DocePLUS, an albumin-stabilized PEGylated liposomal formulation of docetaxel for the treatment of small cell lung cancer.
Recommended Story: Coverage Ratio
Receive News & Ratings for PlusTherapeuticsInc . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PlusTherapeuticsInc . and related companies with MarketBeat.com's FREE daily email newsletter.